Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease
Abstract Soluble CD40 ligand (sCD40L) has been implicated in the development of renal injury. The CD40 receptor exists in a soluble form, sCD40R, and has been shown to function as a competitive antagonist against CD40 activation. We analyzed whether plasma levels of sCD40L and sCD40R predict changes...
Enregistré dans:
Auteurs principaux: | Jeffrey X. Xie, Helen Alderson, James Ritchie, Philip A. Kalra, Yanmei Xie, Kaili Ren, Hanh Nguyen, Tian Chen, Pamela Brewster, Rajesh Gupta, Lance D. Dworkin, Deepak Malhotra, Christopher J. Cooper, Jiang Tian, Steven T. Haller |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/48f5f24ffe304226aa5bceacf2bedcf1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures
par: Esther Pototskiy, et autres
Publié: (2021) -
Author Correction: Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures
par: Esther Pototskiy, et autres
Publié: (2021) -
Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease
par: Michael Lacy, et autres
Publié: (2021) -
Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid
par: Pei Qiao, et autres
Publié: (2017) -
IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study
par: Staszewski J, et autres
Publié: (2018)